Boris Fehse

Head

Universitätsklinikum Hamburg-Eppendorf

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Boris Fehse is the Head at Universitätsklinikum Hamburg-Eppendorf in Germany. His research focuses on innovative approaches in hematopoietic stem cell transplantation and the use of CAR T-cell therapies for various malignancies. He has contributed significantly to the understanding of feto-maternal microchimerism and its clinical implications, as well as the development of predictive models for patient-derived cancer therapies.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Hartmut Schluter

University Professor

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Ingo Müller

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Manfred Jücker

University Medical Center Hamburg-Eppendorf

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Boris Fehse

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation

A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy—case report and literature review

The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the <i>TK.007</i> System

The potential of γδ CAR and TRuC T cells: An unearthed treasure

CARs come to AID

Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR

CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture

Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation

Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs

Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

Collaborators (3)

Hartmut Schluter

Ingo Müller

Manfred Jücker

Make your next move.